NCT02946996 2026-03-05
Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
Medical University of South Carolina
Phase 2 Terminated
Clinical Trials
38 trialsNCT02365597 2026-01-30
An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer
Janssen Research & Development, LLC
Phase 2 Active not recruiting
NCT06044025 2026-01-15
A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation Therapy
University of Arkansas
Phase 1 Recruiting
NCT05515978 2025-12-04
PragMet
University of Colorado, Denver
Phase EARLY_PHASE1 Recruiting
NCT05036226 2025-10-06
COAST
Medical University of South Carolina
Phase 1/2 Recruiting
NCT02339168 2025-05-01
Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate Cancer
University of California, Davis
Phase 1 Completed
NCT06884683 2025-03-19
NivoMet
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 2 Terminated
NCT03031821 2024-10-04
PRIME
Canadian Urologic Oncology Group
Phase 3 Terminated
NCT02431676 2024-08-28
SPIRIT
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT06215976 2024-08-20
The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer
Cairo University
Phase 4 Recruiting
NCT01996696 2024-01-30
PREMIUM
AHS Cancer Control Alberta
Phase 2 Terminated
NCT01864096 2024-01-24
MAST
University Health Network, Toronto
Phase 3 Unknown
NCT03379909 2023-09-21
TROJAN
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 2 Recruiting
NCT02640534 2023-06-27
Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone
Swiss Cancer Institute
Phase 2 Terminated
NCT00268476 2023-04-18
STAMPEDE
Medical Research Council
Phase 2/3 Active not recruiting
NCT02176161 2022-10-18
Metformin Prostate Cancer Adjuvant Trial
NYU Langone Health
Phase 2 Completed
NCT02945813 2022-04-14
SAKK 08/15 - PROMET - Salvage Radiotherapy +/- Metformin for Patients With Prostate Cancer After Prostatectomy
Swiss Cancer Institute
Phase 2 Terminated
NCT02614859 2022-03-29
BIMET-1
Fox Chase Cancer Center
Phase 2 Completed
NCT04925063 2021-06-14
The Effect of Metformin in Patients With Newly Diagnosed mHSPC
Sun Yat-sen University
Phase 2 Not yet recruiting
NCT04926155 2021-06-14
The Effect of Metformin in Patients With Metastatic Castration-resistant Prostate Cancer
Sun Yat-sen University
Phase 2 Unknown
NCT02497638 2021-04-19
LIGAND
University Health Network, Toronto
Phase 2 Withdrawn
NCT02495103 2021-01-26
Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma
National Institutes of Health Clinical Center (CC)
Phase 1/2 Terminated
NCT01243385 2019-08-13
Metformin Hydrochloride as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Prostate Cancer
Swiss Cancer Institute
Phase 2 Completed
NCT01677897 2019-03-05
MetAb-Pro
Kantonsspital Graubünden
Phase 2 Completed
NCT03465345 2018-08-03
Study of Metformin Plus Oligomeric Procyanidin Complex for Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients
Medical University of South Carolina
Phase 1 Withdrawn
NCT01796028 2018-06-06
TAXOMET
Centre Antoine Lacassagne
Phase 2 Completed
NCT01620593 2018-05-23
Castration Compared to Castration Plus Metformin as First Line Treatment for Patients With Advanced Prostate Cancer
The University of Texas Health Science Center at San Antonio
Phase 2 Completed
NCT01433913 2018-01-10
Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery
National Cancer Institute (NCI)
Phase 2 Completed
NCT02376166 2017-12-22
M-RePoRT
Icahn School of Medicine at Mount Sinai
Phase NA Completed
NCT01215032 2017-05-15
Metformin in Castration-Resistant Prostate Cancer
Massachusetts General Hospital
Phase 2 Terminated
NCT03137186 2017-05-02
Mansmed
Mansoura University
Phase 2 Unknown
NCT02360618 2016-07-11
Metformin and Simvastatin Use in Bladder Cancer
London Health Sciences Centre
Phase 2 Unknown
NCT02511665 2015-07-30
METAL
Guy's and St Thomas' NHS Foundation Trust
Phase 4 Unknown
NCT01561482 2015-07-22
Study of Metformin With Simvastatin for Men With Prostate Carcinoma
Baylor College of Medicine
Phase 2 Withdrawn
NCT00659568 2013-05-30
Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma
National Cancer Institute (NCI)
Phase 1 Completed
NCT01733836 2013-05-24
Prostate Cancer Active Surveillance Metformin Trial
University Health Network, Toronto
Phase 2 Withdrawn
NCT01478308 2013-03-06
Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer
New Mexico Cancer Research Alliance
Phase 2 Withdrawn
NCT00881725 2012-06-19
ANIMATE
University Health Network, Toronto
Phase 2 Terminated